Summary
Integrity signals
40 · MediumAutomated screening based on procurement documents and award history. Findings are only shown here once a human reviewer has confirmed them; this is not an allegation of wrongdoing.
-
Specification
· Medium
The specification explicitly names a specific brand-name drug ('FRAXIPARINE') without an 'or equivalent' clause for this specific line item.
-
1.1.4.5. B01AB06 FRAXIPARINE 5700 IU/0.6ML pilnšļirce pilnšļirce 100
-
-
Specification
· Medium
The specification explicitly names a specific brand-name drug ('FRAXIPARINE') without an 'or equivalent' clause for this specific line item.
-
1.1.4.6. B01AB06 FRAXIPARINE 7600 IU/0.8ML pilnšļirce pilnšļirce 200
-
-
Specification
· Medium
The specification explicitly names a specific brand-name drug ('Cyklokapron') without an 'or equivalent' clause for this specific line item.
-
1.2.1. B02AA02 Acidum tranexamicum (Cyklokapron) 500 mg N20 tablete tablete N20 200
-
-
Specification
· Medium
The specification explicitly names a specific brand-name product ('Tachosil') without an 'or equivalent' clause for this specific line item.
-
1.2.2. B02BC30 Fibrinogenum humanum "Tachosil" 2,5x3x0,5 cm plaksteris gab. 65
-
-
Specification
· Medium
The specification explicitly names a specific brand-name drug ('FRAGMIN') without an 'or equivalent' clause for this specific line item, despite the general disclaimer elsewhere in the document.
-
1.1.4.1. B01AB04 FRAGMIN 5000 IU/0.2ml pilnšļirce pilnšļirce 4000
-
Procurement facts
Values and statistics
Authority
No award data available.
Lots
1 lot| Lot | Place and duration | Estimated value | Result |
|---|---|---|---|
| Lot 1 | LVA | Not provided | Not provided |
Documents
1 document| Document | Type and metadata | Link |
|---|---|---|
| Procurement documents | documents_url | Open document |
Notice history
1 notice| Notice | Type and form | Date |
|---|---|---|
| 59f1607f-2934-4f35-b1cd-bbe4c7bf0c41 | pil-prior-information | 2024-06-06 |